Index by author

July 01, 2001; Volume 68, Issue 7

    Ann Marie Hake

  • Use of cholinesterase inhibitors for treatment of Alzheimer disease

    Ann Marie Hake, MD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 608-616;
    • These drugs may slow but do not halt disease progression. They may be most beneficial if started early.

  • Brian Mandell

  • New cholesterol guidelines: Better, but harder to follow

    Brian Mandell, MD, PhD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 579;
    • The new guidelines on lowering cholesterol are good in theory but may prove cumbersome in practice.

  • Bruce H. Cohen

  • Mitochondrial cytopathy in adults: What we know so far

    Bruce H. Cohen, MD and Deborah R. Gold, MD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 625-642;
    • The manifestations of mitochondrial cycopathy are remarkably diverse, and the syndromes identified so far probably represent only a few of the disorders.

  • David J. Muzina

  • Recognizing and treating social anxiety disorder

    David J. Muzina, MD and Samar El-Sayegh, MD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 649-657;
    • Consider this diagnosis when a patient avoids social situations because of marked and persistent fear and anxiety.

  • Deborah R. Gold

  • Mitochondrial cytopathy in adults: What we know so far

    Bruce H. Cohen, MD and Deborah R. Gold, MD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 625-642;
    • The manifestations of mitochondrial cycopathy are remarkably diverse, and the syndromes identified so far probably represent only a few of the disorders.

  • Dennis L. Sprecher

  • Using the new cholesterol guidelines in everyday practice

    Dennis L. Sprecher, MD and Joseph P. Frolkis, MD, PhD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 617-622;
    • Many more patients have become candidates for lipid-lowering therapy under new guidelines recently released.

  • Franklin A. Michota

  • Trends in hospital medicine: Hospitalist advantages revealed

    Franklin A. Michota, MD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 659-662;
    • Available data indicate that hospitalists reduce health care costs while providing care of at least equal quality to that provided by primary care physicians.

  • Joseph P. Frolkis

  • Using the new cholesterol guidelines in everyday practice

    Dennis L. Sprecher, MD and Joseph P. Frolkis, MD, PhD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 617-622;
    • Many more patients have become candidates for lipid-lowering therapy under new guidelines recently released.

  • Mani Kavuru

  • Does salmeterol increase mortality in patients with COPD?

    Robert B. Gerber, MD and Mani Kavuru, MD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 600-601;
    • Salmeterol is safe and FDA-approved, but it should be used only as part of a total program that includes education, smoking cessation, oxygen supplementation, and rehabilitation.

  • Michael Zapor

  • A 47-year-old man with a sore throat

    Marc Williams, MD, Michael Zapor, MD, PhD and Susan L. Fraser, MD
    • Cleveland Clinic Journal of Medicine July 2001, 68 (7) 605-606;
    • Questions and answers on the visible signs of diseases.

Previous
  • 1
  • 2